Ascendis Pharma A/S - ADR
ASND
Market Cap$7.66B
Close$
$158.03
23.3% upside
Current Fair Value
23.3% upsideUndervalued by 23.3% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $7.66 Billion |
|---|---|
| Enterprise Value | $7.83 Billion |
| Dividend Yield | $0 (0%) |
| Earnings per Share | $-8.55 |
| Beta | 0.65 |
| Outstanding Shares | 0 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -16.31 |
|---|---|
| PEG | 41.99 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 23.89 |
| Enterprise Value to EBIT | -23.66 |
| Enterprise Value to Net Income | -19 |
| Total Debt to Enterprise | 0.1 |
| Debt to Equity | -8.13 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About Ascendis Pharma A/S
CEO: Jan Moeller Mikkelsen